PARP Inhibitors Market is estimated to be valued at US$ 8.4 Bn by 2026 – Future Market Insights

By capturing over ¾ of overall revenue value, Olaparib would remain the preferable drug in the PARP inhibitors market. Moreover, Olaparib has received regulatory approval in a majority of regions. Influenced by the rising cancer patient pool, governments all over the world are giving a green signal to novel anti-cancer drugs such as Niraparib and Talazoparib. Although these new drugs are still yet to receive government consent in some developing regions, their rapid uptake is driving huge attention of market players.

The global poly ADP ribose polymerase (PARP) inhibitors market is poised for an exponential growth at a CAGR of 15% during the forecast period (2019-2026). Strong demand from the flourishing pharmaceutical industries a key contributor for this growth projection. PARP inhibitors have gained noteworthy momentum owing to increased awareness about efficacy in terms of treating different types of cancer.

“The unique ability of PARP inhibitors to improve progression-free survival in ovarian and breast cancer patients is expected to generate extensive traction for the market, thereby propelling the growth of the global PARP inhibitors market over the forecast period,” forecasts the FMI report.

Request sample of this report at https://www.futuremarketinsights.com/reports/sample/rep-gb-3197

Key Takeaways of PARP Inhibitors Market Study

  • Olaparib is projected to dominate the global PARP inhibitors market owing to its applications in ovarian cancer, breast cancer, and pancreatic cancer.
  • A number of PARP inhibitors are up for imminent approval owing to a new drug application process.
  • PARP inhibitors are rapidly gaining traction as a new care standard of ovarian cancer treatment following platinum chemotherapy.
  • North America and Europe are projected to remain the dominant regional PARP inhibitors markets owing to better access to new technology and reimbursement policies.
  • Centralizing access to virtual and physical care with the aid of startups, research institutes and government bodies will play a key role in role for the future.

PARP Inhibitors Market – Top Growth Drivers

  • The rising burden of the different cancer types is a key driver behind the demand for PARP inhibitors.
  • The superior efficacy of PARP inhibitors over that of other cancer treatments is expected to drive revenue generation in the forecast period.
  • Faster approval of PARP inhibitor drugs are also anticipated to drive adoption rates, as demand rises.

PARP Inhibitors Market – Key Restraints

  • High costs related to clinical trials, insurance coverage, and testing for drug-drug interactions is a key restraint, particularly for emerging players.
  • The nascent nature of the PARP inhibitors market also builds the risk of such dosages not being included in select electronic records.

Schedule a meeting with expert analysts for detailed insights https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-3197

Competitive Landscape

Some of the key market players profiled in the report include, but are not limited to TESARO Inc., AbbVie Inc., Pfizer Inc., AstraZeneca, CLOVIS ONCOLOGY. Mergers and acquisitions are the key developmental strategies being adopted by leading market players, as the market is projected to remain in a consolidated stage through the forecast period. Such moves will enable manufacturers to widen their scope of regional product offerings. For instance, TESARO Inc., was acquired by Glaxo Smith Kline plc which allowed the latter to expand its product portfolio with the inclusion of Zejula (Niraparib) PARP inhibitor.

More About the Report

The 200-page study offers an in-depth market forecast and analysis on PARP inhibitors market. The major categories encompassed by the report include drug (olaparib, niraparib, rucaparib, and talazoparib), indication (ovarian cancer, breast cancer, prostate cancer, and pancreatic cancer), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies) across seven regions (Middle East & Africa, Oceania, Europe, Latin America, South Asia, East Asia, North America).

Explore Extensive Coverage of FMI’s Healthcare, Pharmaceuticals and Medical Devices Landscape

Liquid Biopsy Market– FMI’s comprehensive analysis on the global liquid biopsy market helps stakeholders identify challenges and opportunities. The study covers key regions, competitive landscape, winning imperatives, and key recommendations.

Narcolepsy Treatment Market– Get actionable insights on the global narcolepsy treatment market covering important market dynamics, current and historical growth parameters, and future growth prospects for 2018-2028.

Protein Expression Technology Market– Find a deep-dive analysis of the global protein expression technology market encompassing market performance parameters, key trends, revenue forecast, and value projection along with market share analysis of key players.

Executive Education Program Market Huge Growth Opportunity between 2021-2031

The Executive Education Program Market is projected to surpass US$ 37.8 Bn in 2021. Driven by high demand for in-personal programs and professional courses to up skill the career, the executive education program market is expected to exhibit compound annual growth rate (CAGR) of 11.2%.

Executive learning is an important tool for global businesses to nurture top leadership talent. With technological advancements in every domain, need for leadership and improved skill have increased and so has the adoption of executive education program. As per Future Market Insights (FMI), the executive education program market registered impressive year-on-year growth rate of 10.0% in 2021.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14070

The use of coaching to increase performance at all levels has been highlighted due to the understanding that engaged, developed people offer considerable value to a company’s performance. Technological advancements, lower coaching costs, and greater accessibility have all led to the expansion of group coaching.

One strategy to ensure the long-term success of diverse hires is to provide coaching. Businesses can also use Artificial Intelligence (AI)-powered coach bots and hyper-personalized nudges from companies such as LEADx, Butterfly.ai, and Qstream, to name a few.

Furthermore, it is not only technology and data science experts that are responsible for using big data; business analytics and artificial intelligence (AI) are also used to solve complicated problems. Understanding and guiding these approaches to achieve corporate goals is the responsibility of organizational leadership, which explains the importance and growing popularity of AI and predictive analytics courses.

Candidates can identify difficulties that analytics, machine learning, and artificial intelligence can tackle if they have a working knowledge of data science. It will also assist them in making the best investments possible in people, data, systems, culture, and organization.

Artificial Intelligence is revolutionizing people’s personal and professional life all around the world, and its simple application to a variety of tasks benefits businesses will boost productivity and outcomes. Employees may comprehend how this game-changing technology can assist the many business activities in an organization in order to instil this new tech-driven economy.

Furthermore, in order to develop more skills in the students many business schools are developing programs with variety of case studies. For instance, Graduate School of Stanford Business has a set of case studies dealing with leadership, strategy, negotiation and online learning, among other topics. The case study form of learning provides on-the-edge learning to candidates in a short span.

Key Takeaways from the Executive Education Program Market Study

  • Pre-designed programs will gain immense popularity as demand for executive courses rises among business owners, holding over 58.6% of total share in 2021.
  • Increasing business opportunities and expansion of banking sector have encouraged the companies to upscale their employees profile. On the back of this, financial services have gained significant popularity, accounting for 21.9% of total market share in 2021.
  • Individual/ private learners will account for a notable share of 55.9% in the market in 2021.
  • In 2021, the U.S. will lead the North America’s executive education programs market backed by presence of the best-known and oldest business schools
  • In 2021, the U.K. is expected to be the most lucrative market in Europe, capturing over 26.2% market share.

“In the highly competitive environment the B-schools are actively engaged in promoting their executive education programs. The offerings in the market are being increasingly promoted as programs designed considering the globally distributed workforce. All such efforts on the part of universities and b-schools are further expected to drive market growth.” says an FMI analyst.

Who is Winning?

Leading players of executive education program market are focused on aggressive promotional strategies, advertisements, and new program launches that will drive sales growth of executive education program globally.

Major players present in the executive education program market are Harvard Business School, Columbia University, MIT Sloan School of Management, Stanford Graduate School of Business, Baruch College, Wharton School of Business, UCLA Anderson School of Business, Kellogg School of Management , Stephen M. Ross School of Management , The University of Chicago Booth School of Business, The University of Texas at Austin, Cornell SC Johnson, Rotman School of Management, Ted Rogers, UBC Sauder School of Business, Durham University – Business School among others.

Executive Education Program Market by CategoryBy Program Type:

  • Customized Programs
  • Pre-designed Programs

By Leadership Level:

  • Business-Owners
  • Junior/ Entry-level Employees
  • Managers
  • Mid-level Employees
  • Senior Executives

By Type of Learner:

  • Group/ Small Team Learners
  • Individual/ Private Learners

By Mode of Learning:

  • In-Person Learning
  • Online Learning

By Duration:

  • Less than 1 Week
  • 1 Week to 1 Month
  • More than 1 Month

By Type of Courses:

  • Management & Leadership
  • Finance & Accounting
  • Strategic Leadership & Innovation
  • Marketing & Sales
  • Business Operations & Entrepreneurship
  • Others

By Industry Type:

  • Consumer Products & Retail
  • Energy & Transportation
  • Financial Services
  • Healthcare & Pharmaceuticals
  • Manufacturing & Industrials
  • Others
  • Professional Services
  • Technology & Communications

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/14070

Global GLP-1 Receptor Agonist Market is set to witness steady growth through 2030

A recent market study published by Future Market Insights (FMI) on the GLP-1 Receptor Agonist Market offers global industry analysis for 2015-2019 & opportunity assessment for 2020-2030. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the market, growth prospects of the market are obtained with utmost precision.

The report features unique and salient factors that may make a huge impact on the development of the GLP-1 Receptor Agonist Market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the market in the years to come. The report provides detailed information about the current and future growth prospects of the market in the most comprehensive way for better understanding of readers.

GLP-1 receptor agonist, also known as incretin mimetics, represents a class of medications used in the treatment of type 2 diabetes mellitus and obesity in adults. Drugs in the GLP-1 Receptor agonist include exenatide, lixisenatide, liraglutide, albiglutide, dulaglutide, and semaglutide. Extensive R&D is a key driver of the GLP-1 receptor agonist market. Several pharmaceutical and biotecnology development companies are engaged in R&D for the development of new formulations and molecules.

To know more about this market, request a sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-12346

Key Takeaways from the GLP-1 Receptor Agonist Market

  • Trulicity held the largest share in terms of revenue generation in 2019
  • Ozempic is expected to witness the highest growth rate between 2020 and 2030 owing to advantages like weight loss, reduction of cardiovascular risk, and controlled levels of haemoglobin
  • Asia Pacific is expected to be growing at the fastest pace due to onslaught of diabetes supporting intake of GLP-1 receptor agonists

Key Segment

Drug Class

  • Exenatide
  • Liraglutide
  • Dulaglutide
  • Lixisenatide
  • Others

Route of Administration

  • Parenteral
  • Oral

Distribution Channel

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Key Players Operating in Global GLP-1 Receptor Agonist Market

However, some time back, Teva did confirm generic Victoza. It also stated that it had filed ANDA (abbreviated new drug application) with the US FDA, thereby asking for approval for marketing Novo Nordisk’s Victoza (Iiraglutide) injection in the US.

The global GLP-1 receptor agonist market is fragmented, with presence of a large number of small-scale and large-scale companies. Leading companies operating in the global GLP-1 receptor agonist market are: Eli Lilly and Company, Novo Nordisk, AstraZeneca, Intarcia Therapeutics, Sanofi, Jiangsu Hengrui Medicine Co., Hanmi Pharmaceutical, PegBio, Pfizer, Amgen, Innovent Biologics

Get Access to Research Methodology Prepared by Experts>>> https://www.futuremarketinsights.com/ask-question/rep-gb-12346

Want more insights?

GLP-1 Receptor Agonist market, a new study from Future Market Insights, states the indications of GLP-1 Receptor Agonist market from 2015 to 2019 and presents demand projections from 2020 from 2030 on the basis of drug class (Exenatide, Liraglutide, Dulaglutide, Lixisenatide, and Others), route of administration (parenteral, oral), distribution channel (Hospitals, Clinics, Ambulatory Surgical Centres) across seven prominent regions. In other words, a snapshot of every sub-section; that too, region-wise is presented in the report by FMI.

Period Panties Market Estimated to Expand at a Robust CAGR By 2030

Future Market Insights (FMI) in its latest study has forecast the global period panties market to grow at 15.8% CAGR between 2020 and 2030.  By the end of 2021, the market’s valuation is expected to reach US$ 180 Mn. The rise in awareness about feminine hygiene coupled with the increase in demand for eco-friendly period panties is projected to present lucrative opportunities for expansion of the market.

An increasing number of women getting conscious about the prevalence of the diseases associated with unhygienic menstrual management practices and they are opting safer ways to maintain the proper menstrual hygiene. According to the National Center for Biotechnology Information (NCBI), women who use reusable absorbent pads are more likely to be diagnosed with at least one urogenital infection than women using disposable pads. Disposable period panties being meant for maintenance of proper hygiene and providing comfort are experiencing surge in demand.

Request a report sample to gain comprehensive market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-10702

The COVID-19 pandemic has affected the sales of the market severely, especially earlier this year. However, the market seems to be recovering steadily owing to the rise in requirement for the safer and more hygienic ways of menstrual management practices. FMI in the study reports growth at decelerated pace in 2020. However, 2021 onwards the market is expected to regain momentum.

FMI offers an in-depth analysis of the market trends, potential, growth, and restraints.

Some of the key takeaways from the report are highlighted below-

  • Brief-styled period panties are increasingly preferred style
  • Disposable period panties will emerge as highly sought after product in the coming years
  • Sales of medium-sized period panties will remain considerably high
  • Maximum sales of period panties are expected to happen via offline sales channels, however, growth exhibited by online channels is expected to happen at a higher rate
  • North America is expected to remain the dominant market for period panties yet East Asia and South Asia are expected to report growth at higher rate

“The demand for hygienic menstrual management has increased the requirement of period panties substantially over the past decade. The rise in concern about maintaining proper female hygiene is forecast to boost the growth of the market further in the coming years. With an increasing number of consumers willing to spend for better comfort, period panties sales are expected to pick up,” says an FMI analyst.

Explore data on the period panties market with 164 figures, 70 tables and the ToC. You will also find market segmentation on https://www.futuremarketinsights.com/reports/period-panties-market

COVID-19 Impact Analysis

The global period panties market has suffered major set-back due to the outbreak of novel coronavirus, during the first half of this year. The sudden lock down followed by the decrease in demand due to the shifted focus towards emergency requirements has slowed down the growth of the market.

While the market is overcoming the restraints such as financial crisis, unavailability of enough raw materials, and others, the demand for period panties is rising again to let the market expand further. According to FMI, the market is likely to get back to its feet by the end of the next year paving new paths to excel for the key market players.

Who is Winning?

The global period panties market has a highly competitive environment. In order to sail through the cut-throat competition, the key market players are focusing on launching of better quality products.

For instance,

  • Knixwear launched its new range of absorbent, machine-washable, and comfortable leakproof period panties such as Leakproof Boyshort, Leakprooof High Rise, Leakproof Bikini, and others in 2020
  • Modibodi launched its new extensive range of period panties such as Seamfree Full Brief Heavy-Overnight Absorbency, High-Waist Bikini Heavy-Overnight Absorbency, and others in 2020. They are focusing on brining quality products for all body types of women to target wider range of consumers

Fire Protection Systems for Industrial Cooking Market to Garner Brimming Revenues by 2029

Prominently driven by rapid increase in establishment of food manufacturing and processing units, adoption of fire protection systems for industrial cooking is further fueled by industrial safety regulatory framework. The market build-up has been solid over the past decade and is set for a healthy CAGR of 6% during the forecast period (2019 – 2029).

Visit For Sample>>https://www.futuremarketinsights.com/reports/sample/rep-gb-1633

A new Future Market Insights (FMI) study reveals that Asian markets are turning highly lucrative for manufacturers of fire protection systems catering to industrial cooking sector, as Asia Pacific has been witnessing strong growth in the commercial kitchen and foodservice industry.

Key Takeaways – Fire Protection Systems for Industrial Cooking Market Study

  • Wireless, automatic, and compact designs in fire alarm systems that fit most industrial layouts, and are compliant with guidelines set by regulatory bodies such as NFPA, are projected to gain more relevance.
  • High installation and maintenance costs of wired alarms will result in reduced preference for these systems in the future.
  • Key players are focused on launching early suppression fast response fire sprinkler systems that are capable of releasing large volumes of water (100 gallons per min), and have improved response time.
  • North America currently represents more than a fourth of the global market value and will continue to lead its way in fire protection systems for industrial cooking market.
  • In the backdrop of a large number of fire incidents in the U.S., strategic collaborations between manufacturers and installers will complement the amplifying demand for fire protection systems in industrial cooking sector.
  • Increasing demand for commercially-prepared food has paved the way for a growing number of food joints and restaurant chains. Robust growth in food ventures has been witnessed in recent years, which is expected to reduce cooking activities within industrial and manufacturing unit premises.

Fire protection systems for industrial cooking are designed and installed in accordance with standards, codes, and rules that are based on actual fire tests. Product customization, with proven advanced fire protection system installations, will play a key role in the value chain of the market.

fire protection systems for industrial cooking market share by region

Competitive Landscape Remains Fragmented

The market structure is considered to be fairly fragmented, with a large number of smaller companies offering identical products. Furthermore, growing number of players in the fire protection systems for industrial cooking market has been driving manufacturers to incorporate forward integration in terms of services, by offering installation, product consultancy, and aftersales support.

Key players such as Honeywell International Inc, Siemens AG, United Technologies Corporation, Emerson Electric Co., Johnson Controls International Plc, and Gentex Corporation hold a prominent share of market pie in terms of revenue, backed by long-term partnerships with consumers and well-established sales networks.

On the other hand, top manufacturers are strategically acquiring regional players, and retaining their brands to expand global presence. For instance, Johnson Controls International Plc provides safety services and solutions such as fire extinguishing systems under many brand names, including Ansul, Tyco Integrated Security, and Tyco SimplexGrinnell.

For any queries linked with the report, ask an analyst >>https://www.futuremarketinsights.com/ask-question/rep-gb-1633

What Lies Ahead for Fire Protection Systems for Industrial Cooking Market?

Increased inclination towards performance efficiency will continue to be the prime driver for the development of technologically-advanced fire protection systems for use in various industries. Most customers are inclined towards purchasing fire protection systems with novel connectivity systems and reduced response times.

Companion Animal Specialty Drugs Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2021-2031

As per the Future Market Insights’ (FMI) study, companion animal specialty drugs sales will increase at 4.21% CAGR between 2021 and 2031. The overall market value is projected to reach US$ 36,104.66 Mn in 2021.

With growing popularity of veterinary science as a profession and increasing adoption of companion animals across the U.S., India, the U.K., and Germany, demand for companion animal specialty drugs will rise.

As per FMI’s analysis, Zoetis Inc., Merck and Co., Inc., Bayer AG, Eli Lily and Co. (Elanco), Merial (Sanofi), Ceva Santé Animale, Virbac Animal Health, and Boehringer Ingelheim GmbH are the top players in the market. These companies are expected to account for over 85% of market share in 2021.

As per ESOMAR-certified consulting firm Future Market Insights (FMI), the global companion animal specialty drugs market registered steady year-on-year (YoY) growth at 5.42% CAGR in 2021.

Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3984

Increasing pet adoption is a major factor, fuelling the demand for animal nutrition and behavioural products, thereby accelerating sales. With increasing rate of obesity among the pet, demand for anti-obesity drugs have burgeoned over the past few years.

Adoption of canine and feline pets increased during the FQ-20, due to the outbreak of COVID-19 and consequent global shutdown. Adoption of dogs is quite high, especially among the geriatric population. This is expected to drive the demand for antibiotics, skin-care, and nutritional products for pets.

As per FMI, the market is expected to reach a valuation of US$ 36,104.66 Mn in 2021 owing to the increasing demand for anti-obesity drugs across veterinary clinics. Alongside this, prevalence of canine vector-borne diseases due to bacteria and protozoa infection will fuel the demand for parasiticides in the next decade.

Key Takeaways from FMI’s Companion Animal Specialty Drugs Market Study

  • By product type, parasiticides will dominate the market, accounting for over 32%of global market share.
  • In terms of distribution channel, veterinary clinics are expected to lead the segment contributing over 52%of value share by 2031
  • In terms of technology type, drying technology is predicted to exceed US$ 89 Bnby end 2031
  • The U.S. will emerge as the leading market across North America backed by the high adoption of pet dogs
  • Germany and the U.K. are anticipated to lead the Europe’s Companion animal specialty drugs market, owing to the growing obesity rate in dogs
  • Increasing cases of neglect and animal cruelty in India will bolster the demand for companion animal specialty drugs through 2021

Speak to Analyst, Questions Related To Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-3984

“The demand for compounded medications and anti-obesity drugs for animals will continue increasing in the coming years. This has encouraged some of the leading companies to focus on research initiatives to launch novel drugs to facilitate improved care for companion animals. This will create impressive growth opportunities in the coming years,” says the FMI analyst.

Competitive Landscape

Zoetis Inc., Merck and Co., Inc., Bayer AG, Eli Lily and Co. and Boehringer Ingelheim GmbH are the key players operating in the companion animal specialty drugs market. among others are some prominent players operating in the Companion animal specialty drugs market.

For instance, in July 2020, Boehringer Ingelheim announced the launch of two new products, NexGard and Broadline, to provide comprehensive parasite treatment for dogs and cats, to expand their product portfolio for the India market.

As per the report, key players are focusing on product introduction and launches to expand their product portfolios. Key player are also involved extensively in strategic acquisition activities which has led to severe competition among companion animal specialty drugs market players.

For example, on August 4,2021, Zoetis, the Parsippany-based animal health company announced the acquisition of a leading Australian-based Jurox’s veterinary medicines, maker of livestock and companion animal medicines.

What else is in the report?

Future market insights offers a unique perspective and actionable insights on companion animal specialty drugs market in its latest study, presenting historical demand assessment from 2016 – 2020 and projections from 2021-2031 based on product type (antibiotics, anti-inflammatory drugs, parasiticides, heartworm, behavioral products, nutritional products, anti-obesity drugs, skin care products and vaccines), distribution channel (veterinary hospitals, veterinary clinics and pharmacies and drug stores) in seven key regions (North America, Latin America, Eastern Europe, Asia Pacific excluding Japan, Western Europe, Japan and Middle East & Africa)

For More Information or Query or Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-3984

Key Questions Answered in the Report

  • What is the current companion animal specialty drugs market value?

The companion animal specialty drugs market is expected to exceed US$36,104.66 Mn in 2021

  • At what rate did the companion animal specialty drugs market grow between 2016 and 2020?

The companion animal specialty drugs market projected steady growth, registering a CAGR at 5.43% between 2016 and 2020.

  • What are the key trends driving companion animal specialty drugs distribution?

Growing demand for compounded medications and increasing adoption of anti-obesity drugs to reduce the growing obesity rate among pets will drive the sales.

  • Who are the leading players of companion animal specialty drugs?

Zoetis Inc., Merck and Co., Inc., Bayer AG, Eli Lily and Co. (Elanco), Merial (Sanofi), Ceva Santé Animale, Virbac Animal Health, and Boehringer Ingelheim GmbH, are the top players FMI identifies as key players.

  • What will be the demand outlook for North America companion animal specialty drugs market?

North America’s companion animal specialty drugs market demand is set to rise at over 3.38% CAGR during the forecast period of 2021 and 2031.

  • What is the market share of leading players in Companion animal specialty drugs market?

The top 10 players in the companion animal specialty drugs market will collectively account for over 85% of global market share in the year 2021.

Labeling Equipment Market Study: An Emerging Hint of Opportunity by 2031

The global labeling equipment market is moderately fragmented with several players operating in the market. However, most key manufacturers have established their presence in prominent countries such as Germany, Italy, China, the U.S., and Japan. According to Future Market Insights, the market will surpass US$ 4.9 Bn by 2031.

Manufacturers present in the German and Italian market offer high-quality and technologically innovative labeling equipment, as compared to other countries. However, these products cost significantly more, creating a fragmented landscape.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-2623

Chinese manufacturers compete based on the per-unit cost as their offerings are available at a lower cost. 60%-70% of the end-user businesses in the Asia-Pacific region are small-scale enterprises that do not have enough funds to import machinery from countries such as Germany, Italy, and the U.S.

Companies have expanded their market presence through acquisitions and merger strategies to mark their presence at a regional level. Low barriers for market entry and consistency in demand, acts as a major influencing factor in the labeling equipment market.

Labeling equipment is projected to experience significant demand in the global market, with significant growth of the healthcare and pharmaceutical industry and elevated usage of e-commerce across the globe.

Key Takeaways in Labeling Equipment Market Study

  • Top labeling equipment is expected to witness accelerated growth with a CAGR of ~5.1% throughout the forecast period, supported by a wider scope of application.
  • Automatic labeling equipment will account for more than 55% of the market share by 2031. Developments in automation and machine learning drive demand.
  • Consumer safety, record keeping, and are factors driving the use of RFID labeling solutions at a CAGR of ~5.4% during the forecast period.
  • India is estimated to account for over 47% of the South Asia value share by 2031. It is also the fastest growing market for labeling equipment in the region.
  • Germany holds the lead in Europe and is holding a market share of over 14% in 2021. The European market is expected to reach a market value of US$ 137 Mn by 2021.

“High performance and productivity with plug-in expansions, improved flexibility, and application with multiple substrates are fueling growth. Robotic integration and customization are a few features that are expected to shape market developments through 2031,” says an FMI analyst.

Pressure-Sensitive Labeling Machines Gain Traction

Pressure-sensitive labeling machines that contain adhesives such as wet glue or hot melt glue are gaining traction. Reduced time and cost requirements are key factors supporting sales. Superior flexibility and wider scope of applications support growth prospects.

These features not only help manufacturers create better products, but also help them with mass customized label orders. The market is expected to develop at a high pace due to ongoing innovations and technological improvements.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-2623

Impact of COVID on Labeling Equipment Market

The pandemic situation has disrupted the flow of workforce and logistic supplies due to lockdowns in many countries. Imports and exports were negatively affected in 2020 due to gaps in the transport chain.

However, a strong boost is expected in 2021-2022 to mitigate losses incurred in 2020. The market is expected to improve with a YOY growth of ~4.5% to 4.6% during 2021 and 2022. COVID-19 has deeply affected the food and pharmaceutical market with variations in consumer consumption patterns, lockdown restrictions, and altered laws in various sectors.

Competitive Landscape

Tier 3 players in the market hold 75-82% of the global labeling equipment value share. Market leaders contribute 20-25% of the global market. Geographical expansion and merger and acquisition strategies are likely to remain important through the coming decade.

Quadrel Labeling Systems, Krones AG, KWT Machine Systems Co. Ltd., Label-Aire, Inc., Sidel Group, Nita Labeling Equipment, FUJI Seal International Inc., Sato Holdings Corporation, Pack Leader Machinery Inc., Accutek Packaging Equipment Co. Inc., Pro Mach, Inc., HERMA Labeling Machines, Sacmi Imola S.C, Langguth, Accraply Inc., Multi Pack Machinery Company, World Pack Automation Systems Private Limited, Evolabel AB, Avery Dennison Corporation and Markem-Imaje Corporation are also some of the notable players in the labeling equipment market.

Pulmonology Devices Market Driven by Increased Use of Advanced Inert Materials to Minimize Adverse Patient Reactions: FMI

The wide scope of devices in pulmonology healthcare, increased number of surgical procedures performed, and faster regulatory approvals are key factors that are expected to generate major growth opportunities in the industry for the coming decade. The pulmonology devices market is estimated to rise at an impressive CAGR of over 10% through the end of the forecast period in 2031. Growing patient awareness about COPD and asthma, and developments in associated government healthcare initiatives will support long term growth in the industry.

“Frequent technological advances, superior portability, and ease of handling for modern pulmonology devices are boosting adoption in home and alternate care settings as well. Furthermore, non-profit and government initiatives, and awareness programs, and an influx of funding for research studies have positively influenced developments within the industry,” says the FMI study.

Request a report sample to gain comprehensive market insights at

https://www.futuremarketinsights.com/reports/sample/rep-gb-13036

Pulmonology Devices Market – Primary Takeaways

  • Disposable, miniaturized bronchoscopes will witness increased uptake owing to lower health risks and ease of handling.
  • Chronic obstructive pulmonary disease treatment applications hold major market share, driven by its high mortality rate.
  • Awareness programs and government incentives have set up Brazil as a high potential market.
  • The U.S. holds major market share on the back of easier access to new healthcare technologies and major investments into medical infrastructure.

Pulmonology Devices Market – Growth Factors

  • Poor atmospheric conditions and widespread prevalence of respiratory ailments is generating demand.
  • Innovations in terms of home care therapeutic devices is creating lucrative growth opportunities.
  • Advances in minimally invasive surgical procedures are contributing to growth within the industry.

Pulmonology Devices Market – Major Constraints

  • Unfavorable reimbursement settings in many countries is a key factor holding back adoption rates.
  • Risk of side effects on neonatal patients is a key challenge restraining market growth.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/13036

Expected Impact on Market by Coronavirus Outbreak

The pulmonology devices market has been moderately affected by the ongoing covid-19 pandemic. While the market has been driven by a high volume of bronchoscopy procedures. Restrictions and postponed elective medical procedures has slowed down adoption rates. In addition, restrictions on trade have disrupted supply chains for essential raw materials and components, limiting short term growth prospects.

On the other hand, the use of specialized pulmonology devices to manage cases of respiratory failures in covid-19 patients frequent innovation in respiratory care technologies, and positive demographic trends, has helped to partially mitigate losses, and will create key lucrative opportunities for revenue generation in the near future.

Competition Landscape

Leading manufacturers operating in the pulmonology devices market include but are not limited to Merit Medical Systems, Boston Scientific Corporation, Micro-Tech (Nanjing) Co. Ltd., CONMED Corporation, Hunan Vathin, Olympus Corporation, United Medical Surgical Services Ltd., Cook Medical Incorporated, Verathon Inc., Medi-Globe GmbH, and Ambu A/S.

Major players in the pulmonology devices market are invested in strategies towards portfolio expansion. This includes efforts of product development and launch in addition to strategic mergers and acquisitions for long-term revenue generation options.

The Translational and Clinical Research Institute at Newcastle University, U.K., developed the novel Exovent negative-pressure ventilator aimed towards patients with respiratory failure, with lower levels of intrusion as compared to CPAP and positive pressure ventilation. GOQii announced approval for three wearable pulmonology devices by the Central Drugs Standard Control Organization in December 2020. Further, Olympus announced the acquisition of Veran Medical Technologies for a valuation of US$ 340 million to widen its portfolio of interventional pulmonology solutions.

Download Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-13036

More on the Report

FMI provides detailed actionable insights on the pulmonology devices market. The market is segmented in terms of product (pulmonary biopsy devices, endobronchial ultrasound needles, airway stents, airway extraction baskets, and single-use bronchoscopes), indication (lung cancer, COPD, foreign body extraction, tracheal and bronchial stenosis, and others), and end user (hospitals, pulmonology clinics, and ambulatory surgical centers), across seven regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa).

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape

Medication Management System Market: Find insights on the medication management system market with analysis of statistics, segments, players, influencers, and business strategies adopted over a 10-year forecast period.

Medical Bionic Implants and Exoskeletons Market: FMI’s report on the medical bionic implants and exoskeleton market provides insights on the market for 2017-2027. The study provides insights on restraining forces, revenue sources, market leaders, and market strategies.

Cancer Tissue Diagnostics Market: An analysis on the cancer tissue diagnostics market with information on opportunities, growth levers, regional markets, restraints, regulatory policies, and strengths of market players.

Subcutaneous Drug Delivery Market Share by 2028: Upcoming Trends and Analysis

The analysts at Future Market Insights (FMI) followed a multidisciplinary approach during the pandemic to study the growth and development of the Subcutaneous Drug Delivery Market. The report features insights on the current growth dynamics and the major revenue reforms prevailing in the market as of 2020 along with the key takeaways over the forecast period 2018 to 2028.

The team of researchers at Future Business Insights are focusing on research and market study to produce different subcutaneous drug delivery market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the subcutaneous drug delivery market.

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-7676

Subcutaneous Drug Delivery Market: Key Players

Some of the global key participants operating in subcutaneous drug delivery market are: Insulet Corporation, Becton Dickinson Company, Consort Medical, West pharmaceuticals services Inc., Ypsomed AG, Elcam Medical, Sc Pharmaceuticals Inc., Steady Med Ltd, Amgen Inc., Sensile medical AG and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Subcutaneous Drug Delivery Market: Segmentation

Global Subcutaneous Drug Delivery market can be segmented on the basis of Product type, Usability, Technology and Distribution channel.

Based on the Product type Subcutaneous Drug Delivery market is segmented as

  • Fillable Injectable
  • Prefilled Injectable

Based on the usability type Subcutaneous Drug Delivery market is segmented as:

  • Disposable subcutaneous drug delivery injectable
  • Reusable subcutaneous drug delivery injectable

Based on the Technology type Subcutaneous Drug Delivery market is segmented as:

  • Jet
  • Spring
  • Gas

Based on the Distribution Channel Subcutaneous Drug Delivery market is segmented as:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug store
  • Online Pharmacies

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-7676

Queries Solved            

What is the size of the overall Subcutaneous Drug Delivery Market in the Healthcare Market and its segments?

What are the key segments and sub-segments in the market?

What are the key drivers, restraints, opportunities, and challenges of the Subcutaneous Drug Delivery Market in the Healthcare Market, and how they are expected to impact the market?

What are the attractive investment opportunities within the Subcutaneous Drug Delivery Market in the Healthcare Market?

What is the Subcutaneous Drug Delivery Market in the Healthcare Market size at the regional and country-level?

What are the key market players focusing on?

What are the strategies for growth adopted by the key players in Subcutaneous Drug Delivery Market in the Healthcare Market?

What are the recent trends in Subcutaneous Drug Delivery Market in the Healthcare Market? (M&A, partnerships, new product developments, expansions)?

What are the challenges to the Subcutaneous Drug Delivery Market in the growth of the Healthcare Market?

What are the key market trends impacting the growth of the Subcutaneous Drug Delivery Market in the Healthcare Market?

Market Background                                   

Reasons to Buy the report

  • The report includes authentic analysis of the market and the present developing trends in the market affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.
  • We provide accurate insights on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.

Our analysts provide detailed market segmentation along with useful insights and extensive reports that other companies fail to include. The report comprises the market trends, key players and shift in the demand throughout the forecasted period.

Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-7676

Herbal Medicinal Products Market to Manage US$ 360.35 Bn by 2031 – Future Market Insights

The herbal medicinal products market revenue totaled US$ 171.62 Bn in 2021, according to Future Market Insights (FMI) study. The overall sales of herbal medicinal products is expected to reach US$ 360.35 Bn by 2031, growing at a CAGR of 7.7 % for 2021 – 2031.

With consumer awareness regarding herbal medicines on the rise, coupled with increasing investments in the promotion of traditional medicine, sales are expected to improve at an accelerated pace. The demand for ayurvedic medicine also will grow, accounting for nearly 57% of herbal medicines sales in 2021.

Global Market Research Report Overview on Herbal Medicinal Products @ https://www.futuremarketinsights.com/press-release/herbal-medicinal-products-market

The global herbal medicinal products market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by shifting trend from conventional medicines to traditional medicines, favorable government regulations, and growing production capacity of manufacturers across the globe. According to the newly published report, “Herbal Medicinal Products Market: Global Industry Analysis.

Government initiatives undertaken around the world, especially in the West to encourage the use of herbal medicine has resulted in the development of mass distribution networks, increasing prescription of homeopathic medications, and demand for Ayurveda treatments.

According to a recent study by Future Market Insights (FMI), these factors have proven crucial at enabling growth in the herbal medicinal market. Sales of herbal medicines are expected to top US$ 171.62 Bn in 2021, at a CAGR of 7.7% during the forecast period (2021-2031).

Soaring concerns pertaining to adverse effects of allopathic medicines has been causing gradual shift of preference in favor of traditional herbal medicines. These medicines are often used for treatment of ailments including neurological diseases, cough, cold & flu, sexual problems, feminine problems, and metabolic diseases. Herbal remedies are used to maintain health and systemic balance, of body functions without sedation and side effects.

View Report Table of Contents, Figures, and Tables@ https://www.futuremarketinsights.com/reports/herbal-medicinal-products-market/toc

In 2015, La Political de Attention Integral a la Saluda Indigene de FUNASA of Brazil promoted traditional systems of health of indigenous communities. Similarly, the government has recognized homeopathic medicines as a medical specialty and included it in the National Health System. Brazil is currently home to around 12,000 homeopathic physicians and 300 homeopathic pharmacists.

As per the World Health Organization (WHO), around 60% of the world’s population is reliant on herbal medicines for primary health care needs. In developing countries, this number accounts for up to 80%. Around 75% of such sales are made through direct user-pharmacy contacts. The growing trend of online pharmacies and mail-on-order purchases drives the demand for self-medication.

The global geriatric population is rapidly expanding with higher life expectancy rates. According to the World Bank, in 1990, the average mortality among geriatric world population was around 6 %, which increased to 9.5% in 2020. The prevalence of chronic diseases associated with an aging population portrays the need for effective medications.

Key Takeaways from Herbal Medicinal Products Market Study

  • Demand for Chinese medicines is expected to grow at 8.2% CAGR through 2031, owing to investments into promotion of traditional Chinese medicine.
  • Retail pharmacies are projected to capture over 23% of the global market by 2031. This is attributed to availability of consumer health products.
  • Europe is the largest revenue-generating region for herbal medicinal products, with Germany accounting for nearly 18% of the regional market in 2031.
  • China holds the leading position in East Asia, and is expected to account for over 49% of the market in 2031.
  • South Asia is the third most lucrative market with India accounting for over 74% of the share in 2031.

A Sample of this report is available upon request@ https://www.futuremarketinsights.com/reports/sample/rep-gb-2722

“Import-export opportunities for local players and government support for new herbal start-ups will continue creating growth opportunities for manufacturers through the assessment period ending in 2031,” says the FMI Analyst

Who is Winning?

Some of the leading manufacturers of herbal medicinal products are focusing on product launch strategies for global expansion objectives, thereby, enhancing their market presence.

  • In 2021, Arkopharma filed a patent for Quercetin and Kaempferol. These products have a genotoxic potential of plant-based preparations containing free flavones.
  • In Aug 2020, Young Living Essential Oils launched the Hand-blown Artisan Glass Diffuser, Cassia Oil-new skincare line, as additions to the Savvy Minerals makeup line. The product includes diffusers, new essential oil blends and essential oil-infused wearable rings.

Buy Full Herbal Medicinal Products Market Report@ https://www.futuremarketinsights.com/checkout/2722

The key market players covered by FMI include Blackmores Limited, Sanofi-Aventis Healthcare PTY Ltd., Arkopharma SA, Nutraceutical Corporation, STADA Arzneimittel AG, Himalaya Global Holdings Ltd, Integria Healthcare, Boiron Group, Young Living Essential Oils, and Mountain Rose Herbs.